Novo's semaglutide among 2nd batch of drugs selected for Medicare price negotiation

[keangkong]

Novo's semaglutide among 2nd batch of drugs selected for Medicare price negotiation

Here are the first two sentences of the article:

The U.S. government has selected the second batch of drugs up for Medicare price negotiations under the Inflation Reduction Act.

The list of 15 medicines includes blockbuster drugs from Novo Nordisk, Pfizer, Bristol Myers Squibb, AstraZeneca, GSK and other companies. Novo’s booming semaglutide franchise for diabetes and obesity is the standout inclusion in this year’s list.

 

[clayd]

"give us a better deal or we'll be forced to pay $1000/month for mounjaro instead"

 

[keangkong]

"give us a better deal or we'll be forced to pay $1000/month for mounjaro instead"

I bet Tracy would cut Medicare a great deal.

 

[clayd]

I guess we know why customs has been seizing so many packages lately.

 

[clayd]

I bet Tracy would cut Medicare a great deal.

"We have a lady in a Tennessee jail who says she can get it for $200/month"

 

[Imnotkidn]

I bet Tracy would cut Medicare a great deal.

If he ever surfaces again

 

[chmuse]

If he ever surfaces again

Don't worry, if they all bail me and Dwight will keep the forum running with terrible jokes until they come back. Maybe I'll even be mean to oyster, just to keep the Tracy vibes around.

 

[exploitedworkerbee]

Wow, this is a huge deal. The first round was specifically selected so as not to make waves with pharma. Actually useful drugs that have some time left on their patents is progress. We’ll see if this goes anywhere. Maybe they can really stick it to novo and get it for 3x the European price instead of 10x

 

[Renaet75]

Novo's semaglutide among 2nd batch of drugs selected for Medicare price negotiation

Here are the first two sentences of the article:

The U.S. government has selected the second batch of drugs up for Medicare price negotiations under the Inflation Reduction Act.

The list of 15 medicines includes blockbuster drugs from Novo Nordisk, Pfizer, Bristol Myers Squibb, AstraZeneca, GSK and other companies. Novo’s booming semaglutide franchise for diabetes and obesity is the standout inclusion in this year’s list.

Yup and it’s not going to be finished until 2026

 

[Peotidethrowaway]

Trump undid all of bidens negotiations, was this included you think?